BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1831945)

  • 1. [8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)-induced clonic seizure in mice].
    Fujii E; Nomoto T
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):29-35. PubMed ID: 1831945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
    Lecci A; Giuliani S; Santicioli P; Maggi CA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):181-9. PubMed ID: 1352548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y; Yamawaki S
    Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H; Laubie M; Schmitt H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice.
    Landry ES; Lapointe NP; Rouillard C; Levesque D; Hedlund PB; Guertin PA
    Eur J Neurosci; 2006 Jul; 24(2):535-46. PubMed ID: 16836640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.
    Bert B; Fink H; Hörtnagl H; Veh RW; Davies B; Theuring F; Kusserow H
    Behav Brain Res; 2006 Feb; 167(2):328-41. PubMed ID: 16256213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
    Bill DJ; Knight M; Forster EA; Fletcher A
    Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of two 5-hydroxytryptamine agonists on head-weaving behaviour in streptozotocin-diabetic mice.
    Fujii E; Nomoto T; Muraki T
    Diabetologia; 1991 Aug; 34(8):537-41. PubMed ID: 1834508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist activity of 8-OH-DPAT.
    Smith CF; Cutts S
    Arch Int Pharmacodyn Ther; 1990; 306():106-13. PubMed ID: 1981664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1986; 89(4):467-71. PubMed ID: 2428076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.
    Carli M; Tranchina S; Samanin R
    Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of 8-OH-DPAT-induced behaviour in rats.
    Berendsen HH; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1990 Oct; 187(1):97-103. PubMed ID: 2148726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.
    Löscher W; Czuczwar SJ
    Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.